• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K/AKT 磷酸化通过上调胆囊癌细胞中的 PGC-1α 和 PGC-1β 来激活 ERRα。

PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer.

机构信息

Department of Hepatobiliary Surgery, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214002, P.R. China.

Department of Malaria Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology (Jiangsu Institute of Parasitic Diseases), Wuxi, Jiangsu 214002, P.R. China.

出版信息

Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12252. Epub 2021 Jun 29.

DOI:10.3892/mmr.2021.12252
PMID:34184087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8258462/
Abstract

The nuclear estrogen‑related receptor‑α (ERRα) is an orphan receptor that has been identified as a transcriptional factor. Peroxisome proliferator‑activated receptor‑γ (PPARγ) coactivator‑1‑α (PGC‑1α) and PPARγ coactivator‑1‑β (PGC‑1β) act as the co‑activators of ERRα. Our previous study reported that activated ERRα promoted the invasion and proliferation of gallbladder cancer cells by promoting PI3K/AKT phosphorylation. Therefore, the aim of the current study was to investigate whether PI3K/AKT phosphorylation could enhance ERRα activity in a positive feedback loop. LY294002 and insulin‑like growth factor I (IGF‑I) were used to inhibit and promote PI3K/AKT phosphorylation, respectively. A 3X ERE‑TATA luciferase reporter was used to measure ERRα activity. The present study found that LY294002 inhibited PI3K/AKT phosphorylation, decreased the proliferation and invasion of NOZ cells and suppressed the activity of ERRα. Conversely, IGF‑I induced PI3K/AKT phosphorylation, promoted the proliferation and invasion of NOZ cells and enhanced the activity of ERRα. The protein expression levels of PGC‑1α and PGC‑1β were elevated and reduced by IGF‑I and LY294002, respectively. Moreover, knockdown of PGC‑1α and PGC‑1β antagonized ERRα activation, which was enhanced by PI3K/AKT phosphorylation. Taken together, the present study demonstrated that PI3K/AKT phosphorylation triggered ERRα by upregulating the expression levels of PGC‑1α and PGC‑1β in NOZ cells.

摘要

核雌激素相关受体-α(ERRα)是一种已被鉴定为转录因子的孤儿受体。过氧化物酶体增殖物激活受体-γ(PPARγ)共激活因子-1-α(PGC-1α)和 PPARγ 共激活因子-1-β(PGC-1β)作为 ERRα 的共激活因子。我们之前的研究报道,激活的 ERRα 通过促进 PI3K/AKT 磷酸化来促进胆囊癌细胞的侵袭和增殖。因此,本研究旨在探讨 PI3K/AKT 磷酸化是否可以在正反馈环中增强 ERRα 的活性。LY294002 和胰岛素样生长因子 I(IGF-I)分别用于抑制和促进 PI3K/AKT 磷酸化。使用 3X ERE-TATA 荧光素酶报告基因来测量 ERRα 活性。本研究发现,LY294002 抑制 PI3K/AKT 磷酸化,降低了 NOZ 细胞的增殖和侵袭,并抑制了 ERRα 的活性。相反,IGF-I 诱导 PI3K/AKT 磷酸化,促进了 NOZ 细胞的增殖和侵袭,并增强了 ERRα 的活性。IGF-I 和 LY294002 分别上调和下调了 PGC-1α 和 PGC-1β 的蛋白表达水平。此外,PGC-1α 和 PGC-1β 的敲低拮抗了由 PI3K/AKT 磷酸化增强的 ERRα 激活。综上所述,本研究表明,PI3K/AKT 磷酸化通过上调 NOZ 细胞中 PGC-1α 和 PGC-1β 的表达水平来触发 ERRα。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a31/8258462/0dcf4bf77abe/mmr-24-02-12252-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a31/8258462/8695c98e91a9/mmr-24-02-12252-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a31/8258462/0dcf4bf77abe/mmr-24-02-12252-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a31/8258462/8695c98e91a9/mmr-24-02-12252-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a31/8258462/0dcf4bf77abe/mmr-24-02-12252-g01.jpg

相似文献

1
PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer.PI3K/AKT 磷酸化通过上调胆囊癌细胞中的 PGC-1α 和 PGC-1β 来激活 ERRα。
Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12252. Epub 2021 Jun 29.
2
Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.雌激素相关受体-α通过增强黏附蛋白-4 的转录促进胆囊癌的发展。
Cancer Sci. 2020 May;111(5):1514-1527. doi: 10.1111/cas.14344. Epub 2020 Feb 29.
3
PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.PGC1α 通过 ERRα 转录调控抑制前列腺癌细胞侵袭。
Cancer Res. 2019 Dec 15;79(24):6153-6165. doi: 10.1158/0008-5472.CAN-19-1231. Epub 2019 Oct 8.
4
Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.下调 ERRα 通过调节 VEGF 产生和 PI3K/Akt/STAT3 信号通路抑制人脐静脉内皮细胞血管生成。
Eur J Pharmacol. 2015 Dec 15;769:167-76. doi: 10.1016/j.ejphar.2015.11.014. Epub 2015 Nov 14.
5
Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.阐明FoxO3a转录因子在胰岛素样生长因子-1诱导的葡萄膜黑色素瘤癌细胞迁移和侵袭中的作用。
Biomed Pharmacother. 2016 Dec;84:1538-1550. doi: 10.1016/j.biopha.2016.11.027. Epub 2016 Nov 20.
6
Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.下调 Rictor 通过阻断食管鳞癌细胞中 mTORC2 介导的 Akt/PRAS40 磷酸化来增强细胞对 PI3K 抑制剂 LY294002 的敏感性。
Biomed Pharmacother. 2018 Oct;106:1348-1356. doi: 10.1016/j.biopha.2018.07.075. Epub 2018 Jul 23.
7
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.PI3K-Akt信号通路的激活促进前列腺癌细胞的侵袭。
Int J Cancer. 2007 Oct 1;121(7):1424-32. doi: 10.1002/ijc.22862.
8
Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.CD9 与 PI3K‑p85 相互作用激活 B 系急性淋巴细胞白血病中的 PI3K/AKT 信号通路。
Oncol Rep. 2021 Jul;46(1). doi: 10.3892/or.2021.8091. Epub 2021 May 26.
9
Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.抑制表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B细胞存活信号通路可增强曲古抑菌素A对人卵巢癌细胞的细胞死亡及迁移作用。
Int J Oncol. 2006 Jul;29(1):269-78.
10
LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.LY‑294002 通过阻断 PI3K/AKT/HIF‑1α 通路增强肝癌对奥沙利铂的化疗敏感性。
Mol Med Rep. 2021 Jul;24(1). doi: 10.3892/mmr.2021.12147. Epub 2021 May 13.

引用本文的文献

1
Hypoglycemic episodes exacerbate skeletal muscle insulin resistance in type 2 diabetes mellitus.低血糖发作会加剧2型糖尿病患者骨骼肌的胰岛素抵抗。
J Adv Pharm Technol Res. 2025 Apr-Jun;16(2):99-105. doi: 10.4103/JAPTR.JAPTR_388_24. Epub 2025 May 19.
2
Deciphering ERR family genes as prognostic and immunological biomarkers through pan-cancer analysis with validation in gallbladder cancer.通过泛癌分析并在胆囊癌中验证,将ERR家族基因解读为预后和免疫生物标志物。
Front Oncol. 2025 Apr 28;15:1525635. doi: 10.3389/fonc.2025.1525635. eCollection 2025.
3
miR-129 Regulates Yak Intramuscular Preadipocyte Proliferation and Differentiation through the PI3K/AKT Pathway.

本文引用的文献

1
Recent Updates on the Involvement of PI3K/AKT/mTOR Molecular Cascade in the Pathogenesis of Hyperproliferative Skin Disorders.PI3K/AKT/mTOR分子级联反应在增生性皮肤病发病机制中的最新研究进展
Front Med (Lausanne). 2021 Apr 30;8:665647. doi: 10.3389/fmed.2021.665647. eCollection 2021.
2
Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis.癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)在胆囊癌中的预后价值;CA 19-9 65 IU/mL是预后的新临界值。
Cancers (Basel). 2021 Mar 4;13(5):1089. doi: 10.3390/cancers13051089.
3
miR-129 通过 PI3K/AKT 通路调控牦牛肌内前体脂肪细胞的增殖和分化。
Int J Mol Sci. 2024 Jan 3;25(1):632. doi: 10.3390/ijms25010632.
4
Knockdown of PGC1α suppresses dysplastic oral keratinocytes proliferation through reprogramming energy metabolism.PGC1α 敲低通过重编程能量代谢抑制发育异常口腔角质细胞增殖。
Int J Oral Sci. 2023 Sep 4;15(1):37. doi: 10.1038/s41368-023-00242-3.
5
The Protective Mechanism of Afuresertib against Esophageal Cancer.阿氟他滨对食管癌的保护机制。
Dis Markers. 2022 Jul 14;2022:1832241. doi: 10.1155/2022/1832241. eCollection 2022.
6
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.环状 RNA 与癌症进展中 PI3K/AKT 信号通路的相互作用。
Signal Transduct Target Ther. 2021 Nov 24;6(1):400. doi: 10.1038/s41392-021-00788-w.
ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation.
ARRB1通过促进TAK1/MAPK信号激活驱动胆囊癌进展。
J Cancer. 2021 Jan 30;12(7):1926-1935. doi: 10.7150/jca.53325. eCollection 2021.
4
The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017.1990年至2017年195个国家和地区胆囊癌和胆道癌的全球、区域和国家负担及其归因风险因素:全球疾病负担研究2017的系统分析
Cancer. 2021 Jul 1;127(13):2238-2250. doi: 10.1002/cncr.33476. Epub 2021 Mar 22.
5
FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.FBXL10 通过增强 ERRα 的单泛素化来促进 ERRα 蛋白稳定性和乳腺癌细胞的增殖。
Cancer Lett. 2021 Apr 1;502:108-119. doi: 10.1016/j.canlet.2021.01.007. Epub 2021 Jan 12.
6
Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease.基于网络的 iPSC 衍生细胞筛选揭示了心脏瓣膜疾病的治疗候选药物。
Science. 2021 Feb 12;371(6530). doi: 10.1126/science.abd0724. Epub 2020 Dec 10.
7
Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.胆囊癌的综合分子特征分析揭示了与微环境相关的亚型。
J Hepatol. 2021 May;74(5):1132-1144. doi: 10.1016/j.jhep.2020.11.033. Epub 2020 Dec 1.
8
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT).卡培他滨联合伊立替康对比伊立替康单药二线治疗晚期胆囊癌的疗效:一项多中心 2 期随机临床试验(GB-SELECT)。
JAMA Oncol. 2021 Mar 1;7(3):436-439. doi: 10.1001/jamaoncol.2020.6166.
9
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.卡瑞利珠单抗联合吉西他滨和顺铂(GEMOX)治疗晚期胆道癌患者的单臂、开放标签、II 期临床试验。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001240.
10
Aging, senescence and mitochondria: the PGC-1/ERR axis.衰老、细胞衰老与线粒体:PGC-1/ERR轴
J Mol Endocrinol. 2021 Jan;66(1):R1-R14. doi: 10.1530/JME-20-0196.